Attending INTERPHEX Global next week? Our new Business Development Manager, Clayton Merritt, will be in attendance and would be happy to discuss our microbiological, analytical, and environmental monitoring capabilities. Reach out to schedule a meeting! #Interphex2025 #Microbiology #CDMO #ConnectwithCambrex -> https://lnkd.in/gTYGJMkE
关于我们
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a growing team of over 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.
- 网站
-
https://www.cambrex.com
Cambrex的外部链接
- 所属行业
- 制è¯ä¸š
- 规模
- 1,001-5,000 人
- 总部
- East Rutherford,New Jersey
- 类型
- ç§äººæŒè‚¡
- 领域
- Drug substance servicesã€Drug product serviceså’ŒAnalytical services
地点
Cambrex员工
-
Dottie Donnelly Brienza
CHRO | C-Suite Leadership Alignment | Culture Building | HR Strategy | Talent Management | M&A | Change Management | OD
-
Rob Duncan
Senior Talent Acquisition Partner at Cambrex; seeking talent in Quality Control, Analytical Development, Chemical Development, Commercial, and…
-
Cara Wykowski
Senior Director, Business Development Certified at Cambrex; Certified Peer to Peer Grief Educator
-
Hamid Parsa
Drug Substance BU Vice President Sales and Business Development Europe/Asia
动æ€
-
We're thrilled to be part of SCI's Process Development Symposium next week. Eric Fang, Ph.D., General Manager and Site Head at Snapdragon Chemistry will be presenting "Evolve Flow Chemistry into Liquid Phase Peptide Synthesis Technology." Learn more: https://lnkd.in/gXfGQFbe SCI? Where Science Meets Business #SCI
-
-
Congratulations to our colleagues at Q1 Scientific for launching their first US-based location in Durham, NC! Now fully operational, Q1 Scientific Durham offers 7 ICH stability chambers covering a range of conditions, including 2-8°C, 25°C/60%RH, 30°C/65%RH, 30°C/75%RH, and 40°C/75%RH, as well as both -20°C and ultra-low (-70°C/-80°C) storage conditions. Contact Kenley Joseph to learn more. #StabilityStorage
-
Many CDMOs talk about seamless operations across facilities, but at Cambrex, collaboration is more than a concept—it’s how we work every day. Through initiatives like cross-site training, poster sessions, and our annual Cambrex Science Day, we empower our experts to share knowledge and develop cutting-edge solutions. ? This science-first approach allows us to deliver exceptional results for our clients and offer innovative capabilities, including end-to-end peptide development and manufacturing. ? Learn how our approach to peptides is delivered across the Cambrex network, as Matthew Bio, Chief Scientific Officer, discusses collaboration in this "Ask Us Anything" interview: https://lnkd.in/daSUG7Zs
-
Attending American Chemical Society's #ACSSpring2025 next week? Hear from Matthew Zart, Ph.D., Group Leader of Analytical Development at Cambrex Charles City presenting "Development and Optimization of Offline and Online Process Analytical Technologies to Monitor Solvent Ratio in Active Pharmaceutical Ingredient Manufacturing" Learn more about the event: https://lnkd.in/eirW_9uD
-
-
Welcome to #DCATweek 2025! The Cambrex team is excited to be in New York City. We look forward to connecting with our business partners and industry colleagues this week. Thank you DCAT (Drug, Chemical & Associated Technologies Association) for organizing the premier event for the bio/pharmaceutical manufacturing industry. #ConnectWithCambrex #DCAT Matthew Bio, Claudio Russolo, Brandon Fincher, Melissa Huang, Montie Bowie, Hamid Parsa, Carlo Farina, Andy Miles, Joe Nettleton, Elena Bejan, MBA, Ph.D., J. Swaroop Mathen, Mike Farragher, Darryl Hester, Kellie Mellish, Jason Blanchard, Corey Uselman, Craig Durr, Danila Oldani, Torie Cantey (MS, BS), Kenley Joseph, Jacqueline Bessey, Natalee Campbell
-
-
Ciao Milano! Cambrex is thrilled to be back at #BioEuropeSpring. Stop by booth 52 to meet Gianluca Di Lernia and Seamus White. #Pharma #Biotech #CDMO?
-
-
Get to know Cambrex's Chief Scientific Officer, Matthew Bio, and the story of Snapdragon Chemistry in this discussion with Raman Sehgal from Molecule to Market.
Now live! ?? Matthew Bio, CSO at Cambrex and president of Snapdragon Chemistry, joins Raman to discuss his decision to stay at post-acquisition and how Snapdragon is driving growth for Cambrex… Listen now - don’t forget to subscribe and leave a rating wherever you get your podcast fix! ??Apple:https://lnkd.in/eyHUKRgi ??Amazon: https://lnkd.in/emxg43Sm ??Spotify: https://lnkd.in/eAqWrUR4 Find out more about Matthew’s episode ?? https://lnkd.in/eVNrp8zb #CDMO #LifeSciences #Pharma
-
-
Join Cambrex at #CPHIJapan April 9-11?in Tokyo! Click here to schedule a meeting with the Cambrex team or visit us at Booth 5P-26:? https://lnkd.in/gvgUQRKR Tommaso Fontana, Takeshi Sugai, and Carlo Farina #Pharma #CDMO #CPHI #ConnectWithCambrex
-
Congratulations to the teams at Snapdragon Chemistry and Pfizer for their recent publication in Organic Process Research and Development, titled "Thermally Hazardous 1,3-Dioxolane Coupling Reaction Required for a Pharmaceutical Candidate Starting Material, Made Safer by Employing Process Safety Data as Key Design of Experiments Output Variables." The article describes the optimization of a ruthenium-catalyzed catechol, terminal-alkyne coupling reaction to form a key benzodioxolane intermediate toward Lotiglipron. This work represents the use of process safety data as DoE output to guide safe reaction condition selection. Read more here: https://lnkd.in/ezAW3Ryz
-